Both in Biotechnology
Calidi Biotherapeutics vs Silexion Therapeutics
Over the past year CLDI returned −97.2% and SLXN returned −99.6%; their daily moves had a correlation of 0.01.
CLDI −97.2% SLXN −99.6%Growth of $1, one year, split-adjusted
| Metric | CLDI | SLXN |
|---|---|---|
| Price | $0.6717 | $0.1423 |
| Market cap | $1.7M | $2.1M |
| Today | −4.29% | −7.11% |
| 1 month | −37.2% | −48.7% |
| 6 months | −82.3% | −97.7% |
| Year to date | −96.4% | −99.3% |
| 1 year | — | −99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $3.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 78.9% | 240.7% |
| Short % of float | 0.9% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).